newsfilter
← Latest News
PR Newswire·

TC BioPharm Announces Formation of Scientific Advisory Board with Renowned Cell Therapy Experts

Dr. Mark Bonyhadi to spearhead SAB EDINBURGH, Scotland, May 18, 2022 /PRNewswire/ -- TC Biopharm (Holdings) PLC ("TC Biopharm" or the "Company") (NASDAQ:TCBP) (NASDAQ:TCBPW), a clinical stage biotechnology company developing platform allogeneic gamm